FI955700A - Menetelmä seuloa aineita, jotka moduloivat interleukiini-5-reseptorista riippuvaa signaalin välitysreittiä soluissa - Google Patents

Menetelmä seuloa aineita, jotka moduloivat interleukiini-5-reseptorista riippuvaa signaalin välitysreittiä soluissa Download PDF

Info

Publication number
FI955700A
FI955700A FI955700A FI955700A FI955700A FI 955700 A FI955700 A FI 955700A FI 955700 A FI955700 A FI 955700A FI 955700 A FI955700 A FI 955700A FI 955700 A FI955700 A FI 955700A
Authority
FI
Finland
Prior art keywords
dependent signal
receptor
interleukine
pct
cells
Prior art date
Application number
FI955700A
Other languages
English (en)
Swedish (sv)
Other versions
FI955700A0 (fi
FI111016B (fi
Inventor
Armin Peter Czernilofsky
Ulrike Weyer
Ian G Young
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI955700A publication Critical patent/FI955700A/fi
Publication of FI955700A0 publication Critical patent/FI955700A0/fi
Application granted granted Critical
Publication of FI111016B publication Critical patent/FI111016B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI955700A 1993-05-27 1995-11-27 Menetelmä seuloa aineita, jotka moduloivat interleukiini-5-reseptorista riippuvaa signaalin välitysreittiä soluissa FI111016B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4317577 1993-05-27
DE4317577A DE4317577A1 (de) 1993-05-27 1993-05-27 Verfahren zum Screenen von Substanzen mit modulierender Wirkung auf einen Interleukin-5-Rezeptor-abhängigen zellulären Signalübertragungsweg
PCT/EP1994/001735 WO1994028170A1 (de) 1993-05-27 1994-05-27 Verfahren zum screenen von substanzen mit modulierender wirkung auf einen interleukin-5-rezeptor-abhängigen zellulären signalübertragungsweg
EP9401735 1994-05-27

Publications (3)

Publication Number Publication Date
FI955700A true FI955700A (fi) 1995-11-27
FI955700A0 FI955700A0 (fi) 1995-11-27
FI111016B FI111016B (fi) 2003-05-15

Family

ID=6488996

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955700A FI111016B (fi) 1993-05-27 1995-11-27 Menetelmä seuloa aineita, jotka moduloivat interleukiini-5-reseptorista riippuvaa signaalin välitysreittiä soluissa

Country Status (17)

Country Link
US (1) US5922549A (fi)
EP (1) EP0701628B1 (fi)
JP (1) JPH08510643A (fi)
KR (1) KR100318188B1 (fi)
CN (1) CN1125467A (fi)
AT (1) ATE162555T1 (fi)
AU (1) AU691816B2 (fi)
CA (1) CA2163549A1 (fi)
DE (2) DE4317577A1 (fi)
DK (1) DK0701628T3 (fi)
ES (1) ES2113109T3 (fi)
FI (1) FI111016B (fi)
HU (1) HU220345B (fi)
NO (1) NO316027B1 (fi)
NZ (1) NZ291131A (fi)
RU (1) RU2139936C1 (fi)
WO (1) WO1994028170A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405350D0 (en) * 1994-03-18 1994-05-04 Sandoz Ltd Organic compounds
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor
WO2002028168A1 (en) * 2000-10-03 2002-04-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education High efficiency regulatable gene expression system
AU2003286684A1 (en) * 2002-10-30 2004-06-07 Gail Bishop Somatic cell gene targeting vectors and methods of use thereof
US20040209246A1 (en) * 2003-04-15 2004-10-21 Agouron Pharmaceuticals, Inc. Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
US20050112551A1 (en) * 2003-11-24 2005-05-26 Agouron Pharmaceuticals, Inc. Dual assay for evaluating activity and cytotoxicity of compounds in the same population of cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor
WO1992013063A1 (en) * 1991-01-18 1992-08-06 Oncogene Science, Inc. Methods of transcriptionally modulating expression of growth factor genes and growth factor receptor genes
WO1993007294A1 (en) * 1991-10-01 1993-04-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Service A method of identifying ligands and antagonists of ligands

Also Published As

Publication number Publication date
KR960702532A (ko) 1996-04-27
AU6997794A (en) 1994-12-20
DK0701628T3 (da) 1998-09-21
WO1994028170A1 (de) 1994-12-08
KR100318188B1 (ko) 2002-06-20
NO316027B1 (no) 2003-12-01
NO954781L (no) 1996-01-23
CN1125467A (zh) 1996-06-26
ATE162555T1 (de) 1998-02-15
ES2113109T3 (es) 1998-04-16
RU2139936C1 (ru) 1999-10-20
HUT73742A (en) 1996-09-30
EP0701628B1 (de) 1998-01-21
CA2163549A1 (en) 1994-12-08
FI955700A0 (fi) 1995-11-27
FI111016B (fi) 2003-05-15
NO954781D0 (no) 1995-11-24
DE4317577A1 (de) 1994-12-01
NZ291131A (en) 1996-10-28
JPH08510643A (ja) 1996-11-12
HU220345B (hu) 2001-12-28
AU691816B2 (en) 1998-05-28
DE59405120D1 (de) 1998-02-26
HU9503363D0 (en) 1996-01-29
EP0701628A1 (de) 1996-03-20
US5922549A (en) 1999-07-13

Similar Documents

Publication Publication Date Title
AU2945592A (en) Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path
Delmas et al. βγ dimers derived from Go and Gi proteins contribute different components of adrenergic inhibition of Ca2+ channels in rat sympathetic neurones
FI955700A (fi) Menetelmä seuloa aineita, jotka moduloivat interleukiini-5-reseptorista riippuvaa signaalin välitysreittiä soluissa
Atanasiu et al. Regulation of herpes simplex virus gB-induced cell-cell fusion by mutant forms of gH/gL in the absence of gD and cellular receptors
Sharfe et al. EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions
AU7974987A (en) Immunoassay based on two ensyme inhibition system
WO1996020954A3 (en) Functionally active domains of signal transducer and activators of transcription (STAT) proteins
ES2121078T3 (es) Clonacion y expresion de anticuerpos monoclonales humanizados contra interleuquina-4 humana.
ATE36413T1 (de) Testverfahren unter verwendung von enzymen als markierungssubstanzen.
DE69126526D1 (de) Verfahren zur zellwachstumshinderung und dazu nützliche verbindungen
Sharma et al. G protein coupled receptor signaled apoptosis is associated with activation of a cation insensitive acidic endonuclease and intracellular acidification
Chen et al. Enhancement of presynaptic calcium current by cysteine string protein
FI972457A (fi) FAS/APO1-reseptorien toiminnan modulaattorit
DE69734204D1 (de) Lichtproduzierender biosensor
Chiarugi et al. LowMrPhosphotyrosine Protein Phosphatase Interacts with the PDGF Receptor Directly via Its Catalytic Site
Saffell et al. NCAM requires a cytoplasmic domain to function as a neurite outgrowth-promoting neuronal receptor
Okamoto et al. Regulation of transmembrane signal transduction of insulin-like growth factor II by competence type growth factors or viral ras p21.
Uyttersprot et al. Requirement for cAMP‐response element (CRE) binding protein/CRE modulator transcription factors in thyrotropin‐induced proliferation of dog thyroid cells in primary culture
Europe-Finner et al. Inhibition of aggregation in Dictyostelium by EGTA-induced depletion of calcium
ES2119992T3 (es) Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt).
DE69734894D1 (de) Testverfahren für antifibrotischen wirkstoff
EP0479834A4 (en) Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
ATE196652T1 (de) In kunstlisches rekombinantes substrat ragg-1 und nativem aggrecan zum studium der proteolytischen wirkung von 'aggrecanase' in zellkultursystemen
WO1998049292A3 (fr) Polypeptides associes a des recepteurs activateurs et leurs applications biologiques
Mitchell et al. Munc18-dependent regulation of synaptic vesicle exocytosis by syntaxin-1A in hippocampal neurons

Legal Events

Date Code Title Description
MA Patent expired